Giacomo Buso: Complex and Fragile Management of Patients with Vascular Ehlers-Danlos Syndrome
Giacomo Buso, Internal Medicine Physician, Angiologist FMH at Spedali Civili Hospital, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Some papers matter more than others. This one does.
Not only because it deals with the complex and fragile management of patients with vascular Ehlers-Danlos syndrome (vEDS), but because of the people behind it.
This work, published on EJCRIM | European Journal of Case Reports in Internal Medicine was developed together with young, motivated medical talents from the State of Palestine, and I am genuinely proud of their commitment, curiosity, and clinical insight throughout the process.
vEDS reminds us daily that medicine is not about protocols alone.
It is about balance, experience, teamwork, and sometimes choosing not to intervene.
Misdiagnosis, inappropriate procedures, or interruption of therapy can have dramatic consequences.
Awareness truly saves lives.
Seeing this article recently cited by QS pro is meaningful, but what matters most to me is the message behind it:
- rare diseases need culture
- complexity needs shared knowledge
- young physicians need opportunities, trust, and mentorship
Spreading awareness about vEDS means protecting patients.
Working with these young colleagues means investing in the future of medicine, even, and especially, in difficult clinical contexts.”
Title: Challenges in the Management of Patients with Vascular Ehlers-Danlos Syndrome: Lessons from three Clinical Cases
Authors: Lara Alayasa, Razan Fiala, Adriana Skafi, Tala Sulaiman, Matteo Lemoli, Giacomo Buso, Maria Lorenza Muiesan
Read the Full Article on European Journal of Case Reports in Internal Medicine/PubMed Central
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 14, 2026, 16:39Yuriy Prokopenko: Advancing Hemostasis Through Scientific Collaboration
-
Aug 14, 2026, 16:26Antonio Paul: The Best Transfusion Is the One That Isn’t Needed
-
Aug 14, 2026, 16:24Thirunavukkarasu Angappan: What mRNA Manufacturing Teaches Us About Scaling Hemophilia Gene Therapy
-
Aug 14, 2026, 16:16Priyanka Raheja: Advancing Multidisciplinary Care for Women with Bleeding Disorders
-
Aug 14, 2026, 16:09Cristina Chang: Hemophilia B Gene Therapy BBM-H901 Approved in Macao
-
Aug 14, 2026, 16:03Muhammad Shaheer Bin Faheem: The Growing Mortality Divide in Thromboembolism and Hypertension
-
Aug 14, 2026, 15:53Peter Jaworski: Plasma Donation Myths and Why Plasma Matters
-
Aug 14, 2026, 15:50John Strouse: Why Older Adults with Sickle Cell Disease Should Be Included in Clinical Trials
-
Aug 14, 2026, 15:44Scott Cameron: Understanding Sex Differences in Platelet Biology